This research led Boyer to found one of the world’s first biotech companies, Genentech, in 1976. Its mission was to manipulate the genes of microorganisms to produce medicines and treatments, and within a year it had developed a proof of concept, using engineered E. coli bacteria to produce the hormone somatostatin.
